活细胞封装市场 - 2018-2028 年全球行业规模、份额、趋势、竞争、机会及预测，按聚合物类型、应用、技术和地区划分

在 2024-2028 年的预测期内，活细胞封装市场预计将以惊人的复合年增长率增长。这可归因于在提高细胞封装技术有效性方面的研发不断增长，以及支持活细胞封装产品开发的政府和私人投资增加等因素。

细胞疗法的增加

活细胞封装技术能以可控方式输送药用细胞成分或生物活性材料，因此能有效地用于细胞疗法，因为它们能将治疗药物直接输送到体内的目标位置。此外，它们不会引起人体免疫系统的任何反应，因此不会被免疫系统攻击或清除。在某些情况下，封装细胞还能执行特定功能，如激活抗癌药物。例如，2021 年，一家名为 Nuvilex 的公司进行了一项研究，将活细胞封装在珠子中，用于治疗胰腺癌。据观察，细胞将非活性抗癌药物伊佛酰胺转化为杀癌形式，这一特殊性质确保了化疗药物直接输送到肿瘤，因此被认为在未来具有潜在用途。

慢性疾病发病率上升

癌症、糖尿病等慢性疾病的发病率在全球范围内不断上升，成为全球关注的主要健康问题。根据国际糖尿病基金会的报告，2021 年约有 5.37 亿成年人患有糖尿病，预计到 2030 年将增至 6.43 亿，到 2045 年将达到 7.83 亿。活细胞包裹技术在治疗慢性疾病（如 1 型糖尿病、癌症和自身免疫性疾病）方面的应用的推出和认知度的提高，预计将推动市场的发展。例如，活细胞包裹技术可用于向 1 型糖尿病患者输送胰岛素分泌细胞，向帕金森病患者输送多巴胺。因此，慢性疾病数量的不断增长为公司纳入和加强活细胞封装技术创造了巨大需求，从而有望在预测期内促进市场增长。

不断加强研发以提高产品功效

随着生物技术的不断发展，公司对活细胞封装技术的研发和投资不断增加，从而提高了活细胞封装技术的开发和临床疗效。主要市场参与者为提高活细胞封装技术的应用和生产而不断增加的投资和相互联系进一步促进了全球活细胞封装市场的增长。例如，2022 年 11 月，领先的生物相容性材料供应商 BIO INX 与微细加工技术领先企业 Nanoscribe 合作，推出了 HYDROBIO INX N400，该产品可实现高分辨率的细胞封装，即 3D 打印，特别适用于 3D 微细加工。此外，2021 年 7 月，一家临床生物技术公司 - PharmaCyte Biotech，利用活细胞封装技术开发出了癌症和糖尿病的靶向治疗方法，并开始了用于研究活细胞封装技术治疗糖尿病的两阶段猪研究的第一阶段。因此，不断发展的研究为公司提供了提高活细胞封装技术的机会。

可定制

TechSci Research 可根据给定的市场数据，按照公司的具体需求提供定制服务。报告可提供以下定制选项：

公司信息

• 其他市场参与者（最多五家）的详细分析和概况。

目录

第 1 章：产品概述

• 市场定义
• 市场范围
  • 市场覆盖范围
  • 研究年份
  • 主要市场细分

第 2 章：研究方法

• 研究目标
• 基准方法
• 主要行业合作伙伴
• 主要协会和二手资料来源
• 预测方法
• 数据三角测量与验证
• 假设和限制

第 3 章：执行摘要

• 市场概述
• 主要市场细分概述
• 主要市场参与者概述
• 主要地区/国家概述
• 市场驱动因素、挑战和趋势概述

第4章：客户之声

第5章：活细胞封装市场前景。

• 市场规模与预测
  • 按价值
• 市场份额与预测
  • 按聚合物类型（海藻酸盐、壳聚糖、硫酸纤维素及其他）
  • 按应用（给药、再生医学、细胞移植和益生菌）
  • 按技术（简单滴注、静电滴注和同轴气流
  • 按公司（2022 年）
  • 按地区
• 产品市场地图

第 6 章 : 亚太地区活细胞封装市场前景

• 市场规模与预测
  • 按价值
• 市场份额与预测
  • 聚合物类型
  • 应用
  • 技术
  • 按国家
• 亚太地区：国家分析
  • 中国 .
  • 印度 .
  • 印度 .
  • 日本
  • 澳大利亚

第 7 章 : 欧洲活细胞封装市场前景

• 市场规模与预测
  • 按价值
• 市场份额与预测
  • 聚合物类型
  • 应用
  • 技术
  • 按国家
• 欧洲：国家分析
  • 法国
  • 德国
  • 英国
  • 意大利
  • 西班牙

第 8 章 : 北美活细胞封装市场前景。

• 市场规模与预测
  • 按价值
• 市场份额与预测
  • 聚合物类型
  • 应用
  • 技术
  • 按国家
• 北美洲：国家分析
  • 美国活细胞封装市场前景
    • 市场规模与预测
      • 按价值
    • 市场份额与预测
      • 聚合物类型
      • 应用
      • 技术
  • 墨西哥活细胞封装市场前景
    • 市场规模与预测
      • 按价值
    • 市场份额与预测
      • 聚合物类型
      • 应用
      • 技术
  • 加拿大活细胞封装市场前景
    • 市场规模与预测
      • 按价值
    • 市场份额与预测
      • 聚合物类型
      • 应用
      • 技术

第9章：南美洲活细胞封装市场前景

• 市场规模与预测
  • 按价值
• 市场份额与预测
  • 聚合物类型
  • 应用
  • 技术
  • 按国家
• 南美洲：国家分析
  • 巴西
  • 阿根廷
  • 哥伦比亚

第 10 章 : 中东和非洲活细胞封装市场前景

• 市场规模与预测
  • 按价值
• 市场份额与预测
  • 聚合物类型
  • 应用
  • 技术
  • 按国家
• 中东和非洲：国家分析
  • 南非 活细胞封装
  • 沙特阿拉伯 活细胞封装
  • 阿联酋 活细胞封装
  • 科威特活细胞封装

第 11 章 ：市场动态

• 驱动因素
• 挑战

第 12 章 ：市场趋势与发展

• 近期动态
• 合併与收购
• 产品开发

第 13 章 ：竞争格局

• 业务概述
• 公司概况
• 产品与服务
• 财务状况（上市公司）
• 近期发展
• SWOT 分析
  • AUSTRIANOVA
  • Merck KGaA
  • Sphere Fluidics Ltd.
  • ViaCyte, Inc.
  • Blacktrace Holdings Ltd. (Dolomite Microfluidics)
  • BIO INX
  • Living Cell Technologies Ltd.
  • Sigilon Therapeutics, Inc.
  • Isogen
  • Diatranz Otsuka Ltd.

第 14 章：战略建议

Live Cell Encapsulation Market is expected to grow with an impressive CAGR in the forecast period of 2024-2028. This can be attributed to factors such as growing research & development in improving the effectiveness of cell encapsulation technologies, along with the rise in governmental and private investments supporting live cell encapsulated product development.

Live cell encapsulation is a bioengineering technology that includes encasing living cells with a material or coating. A distinct variety of materials are used for encapsulation, such as liposomes, hydrogels, and microcapsules.

Moreover, live-cell encapsulation is found to have significant importance in cell therapies as it allows a controlled release of bioactive material or cells and thereby is anticipated to bolster the market growth with the rise in cell therapies across the globe.

Increase in Cell Therapies

The live cell encapsulation delivers the medicinal cell component or bioactive materials in a controlled manner and thus is efficient to be used in cell therapies as they include the delivery of therapeutics directly in the targeted location in the body. Additionally, they do not create any response by the body's immune system and thus aren't attacked or eliminated by the immune system. The encapsulated cells, in some cases, carry out specific functions, such as activating cancer drugs. For instance, in 2021, a company called Nuvilex performed a research study in which the live cells were encapsulated within beads to treat pancreatic cancer. It was observed the cells converted the inactive cancer drug ifosfamide into its cancer-killing form, and this specific property ensures the delivery of the chemotherapeutic drug directly to the tumor and thereby is found to have potential usage in the future.

Rising Prevalence of Chronic Diseases

Chronic diseases such as cancer, diabetes, etc., are rising across the globe and are a major health concern worldwide. According to the report by the International Diabetes Foundation, in 2021, around 537 million adults were affected by diabetes, and it is expected to increase to 643 million by 2030, and by 2045, it will reach 783 million. The introduction and increased awareness about the applications of live cell encapsulation in the treatment of chronic diseases such as type 1 diabetes, cancer, and autoimmune diseases are expected to boost the market. For instance, the live cell encapsulation technology is used for delivering insulin-producing cells to the patient suffering from type 1 diabetes and dopamine delivering in the case of Parkinson's disease. Thus, the growing number of chronic diseases is creating a huge demand for companies to include and enhance live cell encapsulation and thereby is expected to bolster the market growth in the forecast period.

Growing Research & Development to Improve Product Efficacy

The growing expansion of biotechnology with increasing research & development and rising company investments in live cell encapsulation technologies is leading to improvement in the development and clinical efficacy of live cell encapsulation. The growing investment and increased mutual associations to enhance the live cell encapsulation technological application and production by the key market players are further contributing to the growth of the global live cell encapsulation market. For instance, In November 2022, a leading supplier of biocompatible materials- BIO INX, collaborated with Nanoscribe- a microfabrication technology leader and introduced HYDROBIO INX N400- that enables cell encapsulation in high resolution, i.e., 3D printing and is especially designed for 3D microfabrication. Additionally, in July 2021, a clinical biotechnology company -PharmaCyte Biotech, developed targeted treatments for cancer and diabetes using the live-cell encapsulation technique and commenced the first phase of a two-phase pig study used for investigating live-cell encapsulation technology for diabetes treatment. Thus, growing research is providing opportunities for companies to enhance the live cell encapsulation technique.

Market Segmentation

Global Live Cell Encapsulation Market is segmented based on polymer type, application, technique, region, and competitive landscape. Based on polymer type, the market is segmented into alginate, chitosan, cellulose sulfate, and others. Based on application, the market is segmented into drug delivery, regenerative medicine, cell transplantation, and probiotics. Based on technique, the market is segmented into simple dripping, electrostatic dripping, and coaxial airflow. Based on the region, the market is further segmented into North America, Europe, Asia-Pacific, South America, and MEA.

Market Players

AUSTRIANOVA, Merck KGaA, Sphere Fluidics Ltd., ViaCyte, Inc., Blacktrace Holdings Ltd. (Dolomite Microfluidics), BIO INX, Living Cell Technologies Ltd., Sigilon Therapeutics, Inc., Isogen, Diatranz Otsuka Ltd. are some of the major players operating in the Global Live Cell Encapsulation Market.

Report Scope

In this report, Global Live Cell Encapsulation Market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:

Live Cell Encapsulation Market, By Polymer Type:

• Alginate
• Chitosan
• Cellulose Sulfate
• Others

Live Cell Encapsulation Market, By Application:

• Drug Delivery
• Regenerative Medicine
• Cell Transplantation
• Probiotics

Live Cell Encapsulation Market, By Technique:

• Simple Dripping
• Electrostatic Dripping
• Coaxial Airflow

Live Cell Encapsulation Market, By Region:

• North America
  • United States
  • Canada
  • Mexico

• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain

• Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia

• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

• South America
  • Brazil
  • Argentina
  • Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Live Cell Encapsulation Market.

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered.
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Live Cell encapsulation Market Outlook.

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Polymer Type (Alginate, Chitosan, Cellulose Sulfate and Others)
  • 5.2.2. By Application (Drug Delivery, Regenerative Medicine, Cell Transplantation and Probiotics)
  • 5.2.3. By Technique (Simple Dripping, Electrostatic Dripping and Coaxial Airflow
  • 5.2.4. By Company (2022)
  • 5.2.5. By Region
• 5.3. Product Market Map

6. Asia-Pacific Live Cell encapsulation Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. Polymer Type
  • 6.2.2. Application
  • 6.2.3. Technique
  • 6.2.4. By Country
• 6.3. Asia-Pacific: Country Analysis
  • 6.3.1. China Live Cell encapsulation Market Outlook.
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. Polymer Type
      • 6.3.1.2.2. Application
      • 6.3.1.2.3. Technique
  • 6.3.2. India Live Cell encapsulation Market Outlook.
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. Polymer Type
      • 6.3.2.2.2. Application
      • 6.3.2.2.3. Technique
  • 6.3.3. South Korea Live Cell encapsulation Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. Polymer Type
      • 6.3.3.2.2. Application
      • 6.3.3.2.3. Technique
  • 6.3.4. Japan Live Cell encapsulation Market Outlook
    • 6.3.4.1. Market Size & Forecast
      • 6.3.4.1.1. By Value
    • 6.3.4.2. Market Share & Forecast
      • 6.3.4.2.1. Polymer Type
      • 6.3.4.2.2. Application
      • 6.3.4.2.3. Technique
  • 6.3.5. Australia Live Cell encapsulation Market Outlook
    • 6.3.5.1. Market Size & Forecast
      • 6.3.5.1.1. By Value
    • 6.3.5.2. Market Share & Forecast
      • 6.3.5.2.1. Polymer Type
      • 6.3.5.2.2. Application
      • 6.3.5.2.3. Technique

7. Europe Live Cell encapsulation Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. Polymer Type
  • 7.2.2. Application
  • 7.2.3. Technique
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Live Cell encapsulation Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. Polymer Type
      • 7.3.1.2.2. Application
      • 7.3.1.2.3. Technique
  • 7.3.2. Germany Live Cell encapsulation Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. Polymer Type
      • 7.3.2.2.2. Application
      • 7.3.2.2.3. Technique
  • 7.3.3. United Kingdom Live Cell encapsulation Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. Polymer Type
      • 7.3.3.2.2. Application
      • 7.3.3.2.3. Technique
  • 7.3.4. Italy Live Cell encapsulation Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. Polymer Type
      • 7.3.4.2.2. Application
      • 7.3.4.2.3. Technique
  • 7.3.5. Spain Live Cell encapsulation Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. Polymer Type
      • 7.3.5.2.2. Application
      • 7.3.5.2.3. Technique

8. North America Live Cell encapsulation Market Outlook.

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. Polymer Type
  • 8.2.2. Application
  • 8.2.3. Technique
  • 8.2.4. By Country
• 8.3. North America: Country Analysis
  • 8.3.1. United States Live Cell encapsulation Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. Polymer Type
      • 8.3.1.2.2. Application
      • 8.3.1.2.3. Technique
  • 8.3.2. Mexico Live Cell encapsulation Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. Polymer Type
      • 8.3.2.2.2. Application
      • 8.3.2.2.3. Technique
  • 8.3.3. Canada Live Cell encapsulation Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. Polymer Type
      • 8.3.3.2.2. Application
      • 8.3.3.2.3. Technique

9. South America Live Cell encapsulation Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. Polymer Type
  • 9.2.2. Application
  • 9.2.3. Technique
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Live Cell encapsulation Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. Polymer Type
      • 9.3.1.2.2. Application
      • 9.3.1.2.3. Technique
  • 9.3.2. Argentina Live Cell encapsulation Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. Polymer Type
      • 9.3.2.2.2. Application
      • 9.3.2.2.3. Technique
  • 9.3.3. Colombia Live Cell encapsulation Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. Polymer Type
      • 9.3.3.2.2. Application
      • 9.3.3.2.3. Technique

10. Middle East and Africa Live Cell encapsulation Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. Polymer Type
  • 10.2.2. Application
  • 10.2.3. Technique
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Live Cell encapsulation Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. Polymer Type
      • 10.3.1.2.2. Application
      • 10.3.1.2.3. Technique
  • 10.3.2. Saudi Arabia Live Cell encapsulation Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. Polymer Type
      • 10.3.2.2.2. Application
      • 10.3.2.2.3. Technique
  • 10.3.3. UAE Live Cell encapsulation Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. Polymer Type
      • 10.3.3.2.2. Application
      • 10.3.3.2.3. Technique
  • 10.3.4. Kuwait Live Cell encapsulation Market Outlook
    • 10.3.4.1. Market Size & Forecast
      • 10.3.4.1.1. By Value
    • 10.3.4.2. Market Share & Forecast
      • 10.3.4.2.1. Polymer Type
      • 10.3.4.2.2. Application
      • 10.3.4.2.3. Technique

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Mergers & Acquisitions
• 12.3. Product Developments

13. Competitive Landscape

• 13.1. Business Overview
• 13.2. Company Snapshot
• 13.3. Products & Services
• 13.4. Financials (In case of listed companies)
• 13.5. Recent Developments
• 13.6. SWOT Analysis
  • 13.6.1. AUSTRIANOVA
  • 13.6.2. Merck KGaA
  • 13.6.3. Sphere Fluidics Ltd.
  • 13.6.4. ViaCyte, Inc.
  • 13.6.5. Blacktrace Holdings Ltd. (Dolomite Microfluidics)
  • 13.6.6. BIO INX
  • 13.6.7. Living Cell Technologies Ltd.
  • 13.6.8. Sigilon Therapeutics, Inc.
  • 13.6.9. Isogen
  • 13.6.10. Diatranz Otsuka Ltd.

14. Strategic Recommendations